外科理论与实践 ›› 2023, Vol. 28 ›› Issue (06): 496-500.doi: 10.16139/j.1007-9610.2023.06.02
收稿日期:
2023-10-16
出版日期:
2023-11-25
发布日期:
2024-03-04
通讯作者:
王卓颖,E-mail: zhuoyingwang@hotmail.com
基金资助:
WANG Zhuoying(), SHI Yuan, GUO Kai, QIAN Kai
Received:
2023-10-16
Online:
2023-11-25
Published:
2024-03-04
摘要:
儿童及青少年甲状腺癌是一类特殊类型的甲状腺癌,受到越来越广泛的重视。近年来,针对这一疾病的认识,疑点和难点不断浮现。本文将对这些临床挑战作一综述,总结国内外近期研究进展,以期发现更多提升儿童及青少年甲状腺癌诊治水平的宝贵机遇。
中图分类号:
王卓颖, 史苑, 郭凯, 钱凯. 儿童及青少年甲状腺癌诊治的挑战与机遇[J]. 外科理论与实践, 2023, 28(06): 496-500.
WANG Zhuoying, SHI Yuan, GUO Kai, QIAN Kai. Challenges and opportunities in the diagnosis and treatment of thyroid carcinoma in children and young adolescents[J]. Journal of Surgery Concepts & Practice, 2023, 28(06): 496-500.
[1] | 王卓颖, 史苑, 郭凯, 等. 青少年分化型甲状腺癌的诊治:从陌生到规范[J]. 外科理论与实践, 2021, 26(6):497-499. |
WANG Z Y, SHI Y, GUO K, et al. Diagnosis and treatment of differentiated thyroid cancer in adolescents: from unfamiliarity to standardization[J]. J Surg Concepts Pract, 2021, 26(6):497-499. | |
[2] |
GUO K, QIAN K, SHI Y, et al. Clinical and molecular characterizations of papillary thyroid cancer in children and young adults: a multicenter retrospective study[J]. Thyroid, 2021, 31(11):1693-1706.
doi: 10.1089/thy.2021.0003 pmid: 34514877 |
[3] |
VAN DE BERG D J, KUIJPERS A M J, ENGELSMAN A F, et al. Long-term oncological outcomes of papillary thyroid cancer and follicular thyroid cancer in children: a nationwide population-based study[J]. Front Endocrinol (Lausanne), 2022, 13:899506.
doi: 10.3389/fendo.2022.899506 URL |
[4] |
WEBER T, HUMMEL R, VORLÄNDER C, et al. Thyroid surgery in children and adolescents: results from a multi-institutional German and Austrian database[J]. Br J Surg, 2023, 110(12):1808-1814.
doi: 10.1093/bjs/znad255 URL |
[5] | 中国临床肿瘤学会. 中国临床肿瘤学会甲状腺髓样癌诊疗指南[M]. 北京: 人民卫生出版社, 2022. |
Chinese Society of Clinical Oncology. Diagnosis and treatment guidelines for medullary thyroid carcinoma of the Chinese Society of Clinical Oncology[M]. Beijing People's Health Publishing House, 2022. | |
[6] |
HALADA S, BARAN J A, BAUER A J, et al. Clinicopathologic characteristics of pediatric follicular variant of papillary thyroid carcinoma subtypes: a retrospective cohort study[J]. Thyroid, 2022, 32(11):1353-1361.
doi: 10.1089/thy.2022.0239 pmid: 36103376 |
[7] |
KIM S Y, YUN H J, CHANG H, et al. Aggressiveness of differentiated thyroid carcinoma in pediatric patients younger than 16 years: a propensity score-matched analysis[J]. Front Oncol, 2022, 12:872130.
doi: 10.3389/fonc.2022.872130 URL |
[8] |
THIESMEYER J W, EGAN C E, GREENBERG J A, et al. Prepubertal children with papillary thyroid carcinoma present with more invasive disease than adolescents and young adults[J]. Thyroid, 2023, 33(2):214-222.
doi: 10.1089/thy.2022.0098 URL |
[9] |
SUGINO K, NAGAHAMA M, KITAGAWA W, et al. Cutoff age between pediatric and adult thyroid differentiated cancer: is 18 years old appropriate?[J]. Thyroid, 2022, 32(2):145-152.
doi: 10.1089/thy.2021.0255 URL |
[10] | DA SILVA BREDER J R A, ALVES P A G, ARAÚJO M L, et al. Puberty and sex in pediatric thyroid cancer: could expression of estrogen and progesterone receptors affect prognosis?[J]. Eur Thyroid J, 2022, 11(2):e210090. |
[11] |
STOSIC A, FULIGNI F, ANDERSON N D, et al. Diverse oncogenic fusions and distinct gene expression patterns define the genomic landscape of pediatric papillary thyroid carcinoma[J]. Cancer Res, 2021, 81(22):5625-5637.
doi: 10.1158/0008-5472.CAN-21-0761 pmid: 34535459 |
[12] |
NIES M, VASSILOPOULOU-SELLIN R, BASSETT R L, et al. Distant metastases from childhood differentiated thyroid carcinoma: clinical course and mutational landscape[J]. J Clin Endocrinol Metab, 2021, 106(4):e1683-e1697.
doi: 10.1210/clinem/dgaa935 pmid: 33382403 |
[13] |
LEE Y A, LEE H, IM S W, et al. NTRK and RET fusion-directed therapy in pediatric thyroid cancer yields a tumor response and radioiodine uptake[J]. J Clin Invest, 2021, 131(18):e144847.
doi: 10.1172/JCI144847 URL |
[14] |
LI H, HAN R, MENG L, et al. Nodal metastases associa-ted with fusion oncogenes are age dependent in young adult patients with thyroid cancer[J]. J Clin Endocrinol Metab, 2023, 109(1):143-150.
doi: 10.1210/clinem/dgad458 URL |
[15] |
XING Z, QIU Y, ZHU J, et al. Diagnostic performance of adult-based ultrasound risk stratification systems in pe-diatric thyroid nodules: a systematic review and meta-analysis[J]. Front Endocrinol (Lausanne), 2023, 14:1187935.
doi: 10.3389/fendo.2023.1187935 URL |
[16] |
TULI G, MUNARIN J, SCOLLO M, et al. Evaluation of the efficacy of EU-TIRADS and ACR-TIRADS in risk stratification of pediatric patients with thyroid nodules[J]. Front Endocrinol (Lausanne), 2022, 13:1041464.
doi: 10.3389/fendo.2022.1041464 URL |
[17] |
Ren P Y, Liu J, Xue S, et al. Pediatric differentiated thyroid carcinoma: the clinicopathological features and the coexistence of Hashimoto's thyroiditis[J]. Asian J Surg, 2019, 42(1):112-119.
doi: 10.1016/j.asjsur.2017.10.006 URL |
[18] | WON J H, LEE J Y, HONG H S, et al. Thyroid nodules and cancer in children and adolescents affected by Hashimoto's thyroiditis[J]. Br J Radiol, 2018, 91(1087):20180014. |
[19] |
YANG J, PAGE L C, WAGNER L, et al. Thyroid nodules on ultrasound in children and young adults: comparison of diagnostic performance of radiologists' impressions, ACR TI-RADS, and a deep learning algorithm[J]. Am J Roentgenol, 2023, 220(3):408-417.
doi: 10.2214/AJR.22.28231 URL |
[20] |
VAN ROOIJEN J J, VAN TROTSENBURG A S P, VAN DE BERG D J, et al. Complications after thyroidectomy in children: lymph node dissection is a risk factor for permanent hypocalcemia[J]. Front Endocrinol (Lausanne), 2021, 12:717769.
doi: 10.3389/fendo.2021.717769 URL |
[21] |
MAKSIMOSKI M, BAUER A J, KAZAHAYA K, et al. Outcomes in pediatric thyroidectomy: results from a multinational, multi-institutional database[J]. Otolaryngol Head Neck Surg, 2022, 167(5):869-876.
doi: 10.1177/01945998221076065 URL |
[22] |
WU S Y, CHIANG Y J, FISHER S B, et al. Risks of hypoparathyroidism after total thyroidectomy in children: a 21-year experience in a high-volume cancer center[J]. World J Surg, 2020, 44(2):442-451.
doi: 10.1007/s00268-019-05231-4 URL |
[23] |
ZOBEL M J, LONG R, GOSNELL J, et al. Postoperative hypoparathyroidism after total thyroidectomy in children[J]. J Surg Res, 2020, 252:63-68.
doi: S0022-4804(20)30115-3 pmid: 32234570 |
[24] |
SPINELLI C, GHIONZOLI M, BERTOCCHINI A, et al. Factors associated with postoperative hypocalcemia following thyroidectomy in childhood[J]. Pediatr Blood Cancer, 2022, 69(8):e29576.
doi: 10.1002/pbc.v69.8 URL |
[25] |
DEKKER B L, MULLER KOBOLD A C, BROUWERS A H, et al. Bone mineral density in adult survivors of pediatric differentiated thyroid carcinoma: a longitudinal follow-up study[J]. Thyroid, 2021, 31(11):1707-1714.
doi: 10.1089/thy.2021.0179 pmid: 34514857 |
[26] |
中国临床肿瘤学会核医学专家委员会, 中国临床肿瘤学会甲状腺癌专家委员会, 中国医疗保健国际交流促进会甲状腺疾病专业委员会, 等. 儿童及青少年分化型甲状腺癌核医学诊治中国专家共识(2022年版)[J]. 中国癌症杂志, 2022, 32(5):451-468.
doi: 10.19401/j.cnki.1007-3639.2022.05.011 |
The Nuclear Medicine Expert Committee of the Chinese Society of Clinical Oncology, The Thyroid Cancer Expert Committee of the Chinese Society of Clinical Oncology, The Thyroid Disease Professional Committee of the China Association for International Exchange and Promotion of Healthcare, et al. Expert consensus on management of differentiated thyroid carcinoma in children and adolescents (2022 edition)[J]. China Oncol, 2022, 32(5):451-468. | |
[27] |
KUMAR P, DAMLE N A, BAL C. Radioiodine therapy in pediatric differentiated thyroid cancer: dosimetry, clinical care, and future challenges[J]. Clin Nucl Med, 2023, 48(2):158-167.
doi: 10.1097/RLU.0000000000004431 URL |
[28] |
BOJARSKY M, BARAN J A, HALADA S, et al. Outcomes of ATA low-risk pediatric thyroid cancer patients not treated with radioactive iodine therapy[J]. J Clin Endocrinol Metab, 2023, 108(12):3338-3344.
doi: 10.1210/clinem/dgad322 pmid: 37265226 |
[29] |
PASQUAL E, SCHONFELD S, MORTON L M, et al. Association between radioactive iodine treatment for pedia-tric and young adulthood differentiated thyroid cancer and risk of second primary malignancies[J]. J Clin Oncol, 2022, 40(13):1439-1449.
doi: 10.1200/JCO.21.01841 URL |
[30] |
LEBBINK C A, VAN SANTEN H M, DANEMAN A, et al. Does ultrasound really contribute to detection of residual/recurrent disease after pediatric thyroidectomy? Preliminary data supporting a "thyroglobulin-first" approach[J]. Thyroid, 2023, 33(5):645-649.
doi: 10.1089/thy.2022.0576 pmid: 37014072 |
[31] |
MAJEED A K, SATAPATHY S, BALLAL S, et al. Dynamic risk stratification for predicting long-term outcomes in pediatric differentiated thyroid cancers[J]. J Clin Endocrinol Metab, 2023, 108(6):e208-e215.
doi: 10.1210/clinem/dgac731 URL |
[32] |
REDLICH A, LUSTER M, LORENZ K, et al. Age, American Thyroid Association Risk Group, and response to therapy are prognostic factors in children with differentiated thyroid cancer[J]. J Clin Endocrinol Metab, 2022, 107(1):e165-e177.
doi: 10.1210/clinem/dgab622 URL |
[33] |
WIRTH L J, SHERMAN E, ROBINSON B, et al. Efficacy of selpercatinib in RET-altered thyroid cancers[J]. N Engl J Med, 2020, 383(9):825-835.
doi: 10.1056/NEJMoa2005651 URL |
[34] |
HONG D S, DUBOIS S G, KUMMAR S, et al. Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials[J]. Lancet Oncol, 2020, 21(4):531-540.
doi: S1470-2045(19)30856-3 pmid: 32105622 |
[35] | WAGUESPACK S G, TEWARI S O, BUSAIDY N L, et al. Larotrectinib before initial radioactive iodine therapy in pediatric TRK fusion-positive papillary thyroid carcinoma: time to reconsider the treatment paradigm for distantly metastatic disease?[J]. JCO Precis Oncol, 2022, 6:e2100467. |
[36] |
CHEN D Q, ZHOU E Q, CHEN H F, et al. Deciphering pathological behavior of pediatric medullary thyroid cancer from single-cell perspective[J]. PeerJ, 2023, 11:e15546.
doi: 10.7717/peerj.15546 URL |
[37] |
GOLDFARB M, FRANCO A T. Survivorship, quality of life, and transition to adult care for pediatric and adolescent thyroid cancer survivors[J]. Thyroid, 2022, 32(12):1471-1476.
doi: 10.1089/thy.2022.0407 pmid: 36193568 |
[38] |
PEREZ M N, HALADA S, ISAZA A, et al. Health-related quality of life at diagnosis for pediatric thyroid cancer patients[J]. J Clin Endocrinol Metab, 2023, 108(5):e169-e177.
doi: 10.1210/clinem/dgac648 URL |
[1] | 陈潇1,2,张瑞1,2,汤心溢1,2,钱娟3. 交叉特征深度编码网络预测儿童脓毒症[J]. J Shanghai Jiaotong Univ Sci, 2024, 29(1): 131-140. |
[2] | 李雅琴, 谢睿, 李论, 等. 儿童单侧发育性髋关节脱位双下肢差异统计及其影响因素 [J]. 组织工程与重建外科杂志, 2024, 20(1): 97-. |
[3] | 周念, 夭志刚, 浦芸静, 等.
儿童手指挛缩性瘢痕激光治疗体会
[J]. 组织工程与重建外科杂志, 2023, 19(5): 454-. |
[4] | 李健1, 2,朱晔1,关天民1. 考虑肌肉因素的脊柱侧弯矫正的数值模拟方法[J]. J Shanghai Jiaotong Univ Sci, 2023, 28(4): 486-. |
[5] | 何熹, 史苑, 钱凯, 王卓颖. 蛋白质赖氨酸甲基转移酶在甲状腺癌中的研究进展[J]. 外科理论与实践, 2023, 28(06): 563-567. |
[6] | 柳卫. 靶碘联合:进展期分化型甲状腺癌治疗新策略[J]. 外科理论与实践, 2023, 28(06): 520-523. |
[7] | 刘杰, 先柯瑶. 分化型甲状腺癌术后促甲状腺激素抑制治疗的共识和争议[J]. 外科理论与实践, 2023, 28(06): 507-511. |
[8] | 张姣, 闾佳佳, 陆文丽, 张莉丹, 李卫. BCR-FIBCD1-ABL1融合基因阳性的儿童慢性粒细胞白血病一例报道并文献复习[J]. 诊断学理论与实践, 2023, 22(05): 472-479. |
[9] | 林庭伃 综述, 赵艳娜, 费健 审校. 热消融技术治疗甲状腺微小乳头状癌的现况[J]. 外科理论与实践, 2023, 28(05): 477-482. |
[10] | 贺文, 顾建华, 邢戌健, 翁子毅, 费健. 术中发现气管憩室2例病例报告并文献复习[J]. 外科理论与实践, 2023, 28(04): 383-387. |
[11] | 中华医学会内分泌学分会. 老年与儿童青少年糖尿病人群新型冠状病毒感染临床应对指南[J]. 内科理论与实践, 2023, 18(01): 10-12. |
[12] | 邹岩 王飞 郭旭朝 王晨 孟钊. 皮耐克人工真皮修复儿童甲母痣切除后软组织缺损的临床应用[J]. 组织工程与重建外科杂志, 2022, 18(2): 123-. |
[13] | 张天羽, 周东, 洪桢. 《儿童抗NMDAR脑炎治疗的国际共识推荐》解读[J]. 诊断学理论与实践, 2022, 21(06): 677-683. |
[14] | 沈小钰, 沙莎, 殷蕾, 周纬, 骆凝馨, 王雪峰. 儿童原发性肾病综合征动态血压变化特点的临床分析[J]. 诊断学理论与实践, 2022, 21(05): 613-618. |
[15] | 吴春晓, 顾凯, 庞怡, 鲍萍萍, 王春芳, 施亮, 向詠梅, 龚杨明, 窦剑明, 吴梦吟, 付晨, 施燕. 2016年上海市甲状腺癌发病和死亡情况与2002—2016年间变化趋势分析[J]. 外科理论与实践, 2022, 27(01): 58-65. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||